Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Mayuri Chandran, Marianela Candolfi, Diana Shah, Yohei Mineharu, Viveka Nand Yadav, Carl Koschmann, Antonela S. Asad, Pedro R. Lowenstein & Maria G. Castro. (2017) Single vs. combination immunotherapeutic strategies for glioma. Expert Opinion on Biological Therapy 17:5, pages 543-554.
Read now
Read now
Articles from other publishers (27)
Rui Sun & Albert H. Kim. (2022) The multifaceted mechanisms of malignant glioblastoma progression and clinical implications. Cancer and Metastasis Reviews 41:4, pages 871-898.
Crossref
Crossref
Hamidreza Zalpoor, Fatemeh Aziziyan, Mahsa Liaghat, Maryam Bakhtiyari, Abdullatif Akbari, Mohsen Nabi-Afjadi, Razieh Forghaniesfidvajani & Nima Rezaei. (2022) The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumors. Cell Communication and Signaling 20:1.
Crossref
Crossref
Imran Khan, Sadaf Mahfooz, Busra Karacam, Elif Burce Elbasan, Kerime Akdur, Hasiba Karimi, Ayten Sakarcan & Mustafa Aziz Hatiboglu. (2022) Glioma cancer stem cells modulating the local tumor immune environment. Frontiers in Molecular Neuroscience 15.
Crossref
Crossref
Mahmoud S. Alghamri, Kaushik Banerjee, Anzar A. Mujeeb, Ava Mauser, Ayman Taher, Rohit Thalla, Brandon L. McClellan, Maria L. Varela, Svetlana M. Stamatovic, Gabriela Martinez-Revollar, Anuska V. Andjelkovic, Jason V. Gregory, Padma Kadiyala, Alexandra Calinescu, Jennifer A. Jiménez, April A. Apfelbaum, Elizabeth R. Lawlor, Stephen Carney, Andrea Comba, Syed Mohd Faisal, Marcus Barissi, Marta B. Edwards, Henry Appelman, Yilun Sun, Jingyao Gan, Rose Ackermann, Anna Schwendeman, Marianela Candolfi, Michael R. Olin, Joerg Lahann, Pedro R. Lowenstein & Maria G. Castro. (2022) Systemic Delivery of an Adjuvant CXCR4–CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma Immunotherapy. ACS Nano 16:6, pages 8729-8750.
Crossref
Crossref
Silvia Duarte‐Sanmiguel, Ana Panic, Daniel J. Dodd, Ana Salazar‐Puerta, Jordan T. Moore, William R. Lawrence, Kylie Nairon, Carlie Francis, Natalie Zachariah, William McCoy, Rithvik Turaga, Aleksander Skardal, William E. Carson, Natalia Higuita‐Castro & Daniel Gallego‐Perez. (2021) In Situ Deployment of Engineered Extracellular Vesicles into the Tumor Niche via Myeloid‐Derived Suppressor Cells. Advanced Healthcare Materials 11:5, pages 2101619.
Crossref
Crossref
Benjamin T. Himes, Philipp A. Geiger, Katayoun Ayasoufi, Adip G. Bhargav, Desmond A. Brown & Ian F. Parney. (2021) Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications. Frontiers in Oncology 11.
Crossref
Crossref
Yu-Shu Liu, Bor-Ren Huang, Ching-Ju Lin, Ching-Kai Shen, Sheng-Wei Lai, Chao-Wei Chen, Hui-Jung Lin, Chia-Huei Lin, Yun-Chen Hsieh & Dah-Yuu Lu. (2021) Paliperidone Inhibits Glioblastoma Growth in Mouse Brain Tumor Model and Reduces PD-L1 Expression. Cancers 13:17, pages 4357.
Crossref
Crossref
Pilar Calero-Pérez, Shuang Wu, Carles Arús & Ana Paula Candiota. (2021) Immune System-Related Changes in Preclinical GL261 Glioblastoma under TMZ Treatment: Explaining MRSI-Based Nosological Imaging Findings with RT-PCR Analyses. Cancers 13:11, pages 2663.
Crossref
Crossref
Kaushik Banerjee, Felipe J. Núñez, Santiago Haase, Brandon L. McClellan, Syed M. Faisal, Stephen V. Carney, Jin Yu, Mahmoud S. Alghamri, Antonela S. Asad, Alejandro J. Nicola Candia, Maria Luisa Varela, Marianela Candolfi, Pedro R. Lowenstein & Maria G. Castro. (2021) Current Approaches for Glioma Gene Therapy and Virotherapy. Frontiers in Molecular Neuroscience 14.
Crossref
Crossref
Seidu A. Richard. (2020) Explicating the Pivotal Pathogenic, Diagnostic, and Therapeutic Biomarker Potentials of Myeloid-Derived Suppressor Cells in Glioblastoma. Disease Markers 2020, pages 1-13.
Crossref
Crossref
Jian Lu, Zhongye Xu, Hubin Duan, Hongming Ji, Zigang Zhen, Bo Li, Huangsuo Wang, Huoquan Tang, Jie Zhou, Tao Guo, Bin Wu, Dawei Wang, Yueting Liu, Yuhu Niu & Ruisheng Zhang. (2020) Tumor‐associated macrophage interleukin‐β promotes glycerol‐3‐phosphate dehydrogenase activation, glycolysis and tumorigenesis in glioma cells. Cancer Science 111:6, pages 1979-1990.
Crossref
Crossref
Yajing Mi, Na Guo, Jing Luan, Jianghong Cheng, Zhifang Hu, Pengtao Jiang, Weilin Jin & Xingchun Gao. (2020) The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment. Frontiers in Immunology 11.
Crossref
Crossref
Ruo Qiao Chen, Feng Liu, Xin Yao Qiu & Xiao Qian Chen. (2019) The Prognostic and Therapeutic Value of PD-L1 in Glioma. Frontiers in Pharmacology 9.
Crossref
Crossref
Chia-Ing Jan, Wan-Chen Tsai, Horng-Jyh Harn, Woei-Cherng Shyu, Ming-Chao Liu, Hsin-Man Lu, Shao-Chih Chiu & Der-Yang Cho. (2018) Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme. Frontiers in Immunology 9.
Crossref
Crossref
Neha Kamran, Mahmoud S Alghamri, Felipe J Nunez, Diana Shah, Antonela S Asad, Marianela Candolfi, David Altshuler, Pedro R Lowenstein & Maria G Castro. (2018) Current state and future prospects of immunotherapy for glioma. Immunotherapy 10:4, pages 317-339.
Crossref
Crossref
Richard G. Everson & Linda M. Liau. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
681
692
.
Tanner M. Johanns & Gavin P. Dunn. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
653
668
.
David A. Reardon, Patrick Y. Wen, Kai W. Wucherpfennig & John H. Sampson. (2017) Immunomodulation for glioblastoma. Current Opinion in Neurology 30:3, pages 361-369.
Crossref
Crossref
Richard E Kast, Quentin A Hill, Didier Wion, Håkan Mellstedt, Daniele Focosi, Georg Karpel-Massler, Tim Heiland & Marc-Eric Halatsch. (2017) Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin. Tumor Biology 39:5, pages 101042831769979.
Crossref
Crossref
R.G. Everson, J.P. Antonios, A.M. Tucker & L.M. Liau. 2017. Translational Immunotherapy of Brain Tumors. Translational Immunotherapy of Brain Tumors
301
321
.
K.A. Riccione, P. Gedeon, L. Sanchez-Perez & J.H. Sampson. 2017. Translational Immunotherapy of Brain Tumors. Translational Immunotherapy of Brain Tumors
261
300
.
Chloé Najac, Myriam M. Chaumeil, Gary Kohanbash, Caroline Guglielmetti, Jeremy W. Gordon, Hideho Okada & Sabrina M. Ronen. (2016) Detection of inflammatory cell function using 13C magnetic resonance spectroscopy of hyperpolarized [6-13C]-arginine. Scientific Reports 6:1.
Crossref
Crossref
Armin Hirbod-Mobarakeh, Masoud Mirghorbani, Fatemeh Hajiju, Mahnaz Marvi, Kiandokht Bashiri & Nima Rezaei. (2016) Myeloid-derived suppressor cells in gastrointestinal cancers: A systematic review. Journal of Gastroenterology and Hepatology 31:7, pages 1246-1256.
Crossref
Crossref
Carolina Melero-Jerez, María Cristina Ortega, Verónica Moliné-Velázquez & Diego Clemente. (2016) Myeloid derived suppressor cells in inflammatory conditions of the central nervous system. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1862:3, pages 368-380.
Crossref
Crossref
Katalin Eder & Bernadette Kalman. (2015) The Dynamics of Interactions Among Immune and Glioblastoma Cells. NeuroMolecular Medicine 17:4, pages 335-352.
Crossref
Crossref
Matthias Preusser, Michael Lim, David A. Hafler, David A. Reardon & John H. Sampson. (2015) Prospects of immune checkpoint modulators in the treatment of glioblastoma. Nature Reviews Neurology 11:9, pages 504-514.
Crossref
Crossref
Jun Yan, Ling-Yuan Kong, Jiemiao Hu, Konrad Gabrusiewicz, Denada Dibra, Xueqing Xia, Amy B. Heimberger & Shulin Li. (2015) FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas. JNCI: Journal of the National Cancer Institute 107:8.
Crossref
Crossref